-Reuters
Pliant Therapeutics Q2 EPS $(0.64) Up From $(1.39) YoY, Sales $1.79M Down From $3.60M YoY
Pliant Therapeutics (NASDAQ:PLRX) reported quarterly losses of $(0.64) per share. This is a 53.96 percent increase over losses of $(1.39) per share from the same period last year. The company reported $1.79 million in